ChinaBiz Briefing: First Commercial BCI, Cambricon’s Profit Surge, and Apple Lowers China Fee to 25%
The Big Picture:
China’s hard-tech sector is crossing a critical threshold from experimental to operational. Today’s news highlights a maturing ecosystem where domestic AI chipmakers are finally printing profits, and medical regulators are moving faster than the FDA to commercialize invasive brain-computer interfaces (BCI). Meanwhile, Apple’